Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2020

View Archived Issues

Multistep method wrests causality from GWAS

Loss of neurofibromin enhances ER function and therapy resistance in ER+ breast cancer

Axim Biotechnologies completes preclinical drug studies on SPX-1009

IND application for CS-12192 accepted in China

Intravitreal Eylea approved for neovascular glaucoma

Latuda tablets approved in Japan

Stelara approved for adults with moderate to severe ulcerative colitis in Japan

Phase I data presented for GDC-0214

Novel fungal mouse model of chronic rhinosinusitis

Sanofi receives approval for Soliqua, a combination agent to treat type 2 diabetes, in Japan

Dupixent approved for additional indication of chronic rhinosinusitis with nasal polyp

IL-4 receptor is a therapeutic target in atopic dermatitis

Genentech presents new IRE1 inhibitors

Betta Pharmaceuticals divulges PD-1/PD-L1 and/or PD-L1/CD80 interaction inhibitors

NiKang Therapeutics synthesizes HIF2A inhibitors

Medicenna presents preclinical data on IL-2 Superkine MDNA-19

Velexbru approved in Japan for recurrent or refractory primary central nervous system lymphoma

Japan first in world to approve Viltepso for Duchenne muscular dystrophy

Medshine Discovery identifies new KDM1A inhibitors

Chengdu Kanghong Pharmaceutical patents new analgesics

Japanese approval of Lokelma for hyperkalemia

Scorpion venom could be useful in fetal alcohol spectrum disorders

Phase I data with inzomelid support progression to phase II

Sun Pharma begins healthy volunteer study of SCO-120

LB-1148 improves bowel function after cardiovascular surgery in phase II trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...